Last Updated: February 24, 2021
Result type: Reports
Generic Name: human insulin
Indications: To
improve glycemic control in adults and children with diabetes mellitus
requiring more than 200 units of insulin per day.
Last Updated: February 24, 2021
Result type: Reports
Generic Name: romosozumab
Indications: The treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture.
Last Updated: December 22, 2020
Result type: Reports
Generic Name: budesonide
Indications: Indicated for the induction and maintenance of clinico-pathological remission in adults with eosinophilic esophagitis (EoE).
Last Updated: December 22, 2020
Result type: Reports
Generic Name: nintedanib
Indications: Treatment of other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype (also known as progressive fibrosing ILD)
Last Updated: February 24, 2021
Result type: Reports
Generic Name: osimertinib
Indications: Tagrisso (osimertinib) is indicated as adjuvant therapy after tumour resection in patients with stage IB-IIIA non-small cell lung cancer (NSCLC) whose tumours have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations. • A validated test is required to identify EGFR mutation-positive status (exon 19 deletions or exon 21 (L858R) substitution mutations) prior to treatment.
Last Updated: February 23, 2021
Result type: Reports
Generic Name: luspatercept
Indications: Reblozyl (luspatercept for injection) is indicated for: the treatment of adult patients with red blood cell (RBC) transfusion-dependent anemia associated with beta(β)-thalassemia. the treatment of adult patients with transfusion-dependent anemia requiring at least two RBC units over 8 weeks resulting from very low- to intermediate-risk myelodysplastic syndromes (MDS) who have ring sideroblasts and who have failed or are not suitable for erythropoietin-based therapy.
Last Updated: February 23, 2021
Result type: Reports
Generic Name: budesonide/ glycopyrronium /formoterol fumarate
Indications: budesonide/ glycopyrronium /formoterol fumarate is a combination of an inhaled corticosteroid (ICS), long-acting muscarinic antagonist (LAMA), and a long-acting beta2-adrenergic agonist (LABA), indicated for the long-term maintenance treatment to reduce exacerbations of chronic obstructive pulmonary disease (COPD), and to relieve symptoms in patients with COPD, including chronic bronchitis and/or emphysema.
Last Updated: February 23, 2021
Result type: Reports
Generic Name: risperidone
Indications: Treatment of schizophrenia in adults.
Last Updated: February 23, 2021
Result type: Reports
Generic Name: givosiran
Indications: Treatment of acute hepatic porphyria (AHP) in adults
Last Updated: February 23, 2021
Result type: Reports
Generic Name: daunorubicin and cytarabine
Indications:
For the treatment of adults with newly diagnosed therapy-related
acute myeloid leukaemia (t-AML) or AML with myelodysplasia-related changes
(AML-MRC).
